Treatment of OSA with continuous positive airway pressure (CPAP) has improved endothelial dysfunction, insulin sensitivity, decreased systemic blood pressure, pulmonary artery pressure, and reduced atrial fibrillation risk [13,19,20,21,22,23,24,25]. This evidence concerns the gene INS and obstructive sleep apnea syndrome.